Literature DB >> 6757025

A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.

F B Stentz, R K Wright, A E Kitabchi.   

Abstract

We have used two methods for the preparation of a highly homogeneous insulin with high specific activity. After iodination with chloramine T, the labeled peptides were retained on a disposable Sep Pak cartridge and subsequently eluted. The eluted labeled insulins were further purified by either DEAE cellulose or high performance liquid chromatography (HPLC) to separate A14-125I- from A19-125I-insulin. Both methods of chromatography were effective, but HPLC offered the advantage of better resolution in less time and higher yields of A14-125I-insulin, which is suitable for biologic studies in various target tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757025     DOI: 10.2337/diacare.31.12.1128

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Degradation of insulin by trypsin and alpha-chymotrypsin.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

2.  Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.

Authors:  Norio Kanatsuna; Jalal Taneera; Fariba Vaziri-Sani; Nils Wierup; Helena Elding Larsson; Ahmed Delli; Hanna Skärstrand; Alexander Balhuizen; Hedvig Bennet; Donald F Steiner; Carina Törn; Malin Fex; Åke Lernmark
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

3.  Etiopathogenesis of insulin autoimmunity.

Authors:  Norio Kanatsuna; George K Papadopoulos; Antonis K Moustakas; Ake Lenmark
Journal:  Anat Res Int       Date:  2012-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.